Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 425 entries
Sorted by: Best Match Show Resources per page
Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design.

Iranian journal of pharmaceutical research : IJPR

Mohtar N, A K Khan N, Darwis Y.
PMID: 26664366
Iran J Pharm Res. 2015;14(4):989-1000.

Solid lipid nanoparticles of atovaquone (ATQ-SLN) were prepared by high shear homogenization method using tripalmitin, trilaurin, and Compritol 888 ATO as the lipid matrices and Phospholipon 90H, Tween 80, and poloxamer 188 as the surfactants. Optimization of the formulations...

Cite
Mohtar N, A K Khan N, Darwis Y. Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design. Iran J Pharm Res. 2015;14(4):989-1000
Mohtar, N., A K Khan, N., & Darwis, Y. (2015). Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design. Iranian journal of pharmaceutical research : IJPR, 14(4), 989-1000.
Mohtar, Noratiqah, et al. "Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design." Iranian journal of pharmaceutical research : IJPR vol. 14,4 (2015): 989-1000.
Mohtar N, A K Khan N, Darwis Y. Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design. Iran J Pharm Res. 2015;14(4):989-1000. PMID: 26664366; PMCID: PMC4673927.
Copy Download .nbib Format: NLM
Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion.

Journal of thrombosis and thrombolysis

Kelly RF, Hursey TL, Patel RB, Parrillo JE, Schaer GL.
PMID: 10767120
J Thromb Thrombolysis. 1998 Jul;5(3):239-247. doi: 10.1023/A:1008848026759.

Poloxamer 188 is a surfactant with hemorheological, antithrombotic, and neutrophil-inhibitory properties. This agent has been demonstrated to reduce infarct size and to improve left ventricular function in animal models of myocardial infarction and reperfusion, and recently in a randomized...

Cite
Kelly RF, Hursey TL, Patel RB, et al. Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion. J Thromb Thrombolysis. 1998;5(3):239-247doi: 10.1023/A:1008848026759.
Kelly, R. F., Hursey, T. L., Patel, R. B., Parrillo, J. E., & Schaer, G. L. (1998). Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion. Journal of thrombosis and thrombolysis, 5(3), 239-247. https://doi.org/10.1023/A:1008848026759
Kelly, et al. "Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion." Journal of thrombosis and thrombolysis vol. 5,3 (1998): 239-247. doi: https://doi.org/10.1023/A:1008848026759
Kelly RF, Hursey TL, Patel RB, Parrillo JE, Schaer GL. Effect of Poloxamer 188 on Collateral Blood Flow, Myocardial Infarct Size, and Left Ventricular Function in a Canine Model of Prolonged (3-Hour) Coronary Occlusion and Reperfusion. J Thromb Thrombolysis. 1998 Jul;5(3):239-247. doi: 10.1023/A:1008848026759. PMID: 10767120.
Copy Download .nbib Format: NLM
FLOCOR: a new anti-adhesive, rheologic agent.

Expert opinion on investigational drugs

Emanuele RM.
PMID: 15992024
Expert Opin Investig Drugs. 1998 Jul;7(7):1193-200. doi: 10.1517/13543784.7.7.1193.

FLOCOR (purified poloxamer 188) is a surfactant molecule that represents a new class of pharmacological agent. FLOCOR is different in that its activity does not depend on high affinity receptor binding but rather on altering the way cells and...

Cite
Emanuele RM. FLOCOR: a new anti-adhesive, rheologic agent. Expert Opin Investig Drugs. 1998;7(7):1193-200doi: 10.1517/13543784.7.7.1193.
Emanuele, R. M. (1998). FLOCOR: a new anti-adhesive, rheologic agent. Expert opinion on investigational drugs, 7(7), 1193-200. https://doi.org/10.1517/13543784.7.7.1193
Emanuele, R M. "FLOCOR: a new anti-adhesive, rheologic agent." Expert opinion on investigational drugs vol. 7,7 (1998): 1193-200. doi: https://doi.org/10.1517/13543784.7.7.1193
Emanuele RM. FLOCOR: a new anti-adhesive, rheologic agent. Expert Opin Investig Drugs. 1998 Jul;7(7):1193-200. doi: 10.1517/13543784.7.7.1193. PMID: 15992024.
Copy Download .nbib Format: NLM
Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant.

Applied and environmental microbiology

Berkelman RL, Anderson RL, Davis BJ, Highsmith AK, Petersen NJ, Bond WW, Cook EH, Mackel DC, Favero MS, Martone WJ.
PMID: 16346513
Appl Environ Microbiol. 1984 Apr;47(4):752-6. doi: 10.1128/aem.47.4.752-756.1984.

After an outbreak of peritoneal infections attributed to intrinsic contamination of a poloxamer-iodine solution with Pseudomonas aeruginosa, the manufacturer of the contaminated solution permitted investigation and sampling of materials within the plant. Pseudomonas spp. were recovered from two different...

Cite
Berkelman RL, Anderson RL, Davis BJ, et al. Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant. Appl Environ Microbiol. 1984;47(4):752-6doi: 10.1128/aem.47.4.752-756.1984.
Berkelman, R. L., Anderson, R. L., Davis, B. J., Highsmith, A. K., Petersen, N. J., Bond, W. W., Cook, E. H., Mackel, D. C., Favero, M. S., & Martone, W. J. (1984). Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant. Applied and environmental microbiology, 47(4), 752-6. https://doi.org/10.1128/aem.47.4.752-756.1984
Berkelman, R L, et al. "Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant." Applied and environmental microbiology vol. 47,4 (1984): 752-6. doi: https://doi.org/10.1128/aem.47.4.752-756.1984
Berkelman RL, Anderson RL, Davis BJ, Highsmith AK, Petersen NJ, Bond WW, Cook EH, Mackel DC, Favero MS, Martone WJ. Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant. Appl Environ Microbiol. 1984 Apr;47(4):752-6. doi: 10.1128/aem.47.4.752-756.1984. PMID: 16346513; PMCID: PMC239760.
Copy Download .nbib Format: NLM
Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.

Scientia pharmaceutica

Nakarani M, Patel P, Patel J, Patel P, Murthy RS, Vaghani SS.
PMID: 21179351
Sci Pharm. 2010 Apr-Jun;78(2):345-61. doi: 10.3797/scipharm.0908-12. Epub 2010 Apr 26.

Cyclosporine A-nanosuspensions were prepared using zirconium oxide beads as a milling media, Poloxamer 407 as a stabilizer and distilled water as an aqueous medium using the Pearl Milling technique. The optimized formulation was characterized in terms of particle size...

Cite
Nakarani M, Patel P, Patel J, et al. Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation. Sci Pharm. 2010;78(2):345-61doi: 10.3797/scipharm.0908-12.
Nakarani, M., Patel, P., Patel, J., Patel, P., Murthy, R. S., & Vaghani, S. S. (2010). Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation. Scientia pharmaceutica, 78(2), 345-61. https://doi.org/10.3797/scipharm.0908-12
Nakarani, Mahendra, et al. "Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation." Scientia pharmaceutica vol. 78,2 (2010): 345-61. doi: https://doi.org/10.3797/scipharm.0908-12
Nakarani M, Patel P, Patel J, Patel P, Murthy RS, Vaghani SS. Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation. Sci Pharm. 2010 Apr-Jun;78(2):345-61. doi: 10.3797/scipharm.0908-12. Epub 2010 Apr 26. PMID: 21179351; PMCID: PMC3002797.
Copy Download .nbib Format: NLM
Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel.

Clinical ophthalmology (Auckland, N.Z.)

Doan S.
PMID: 22275810
Clin Ophthalmol. 2012;6:71-7. doi: 10.2147/OPTH.S26105. Epub 2012 Jan 11.

Commonly associated with dry eye, blepharitis is the most commonly encountered disorder in general ophthalmologic practice. Although anti-infective and anti-inflammatory therapies are available, eyelid hygiene is the cornerstone of effective management. A variety of products have been used to...

Cite
Doan S. Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel. Clin Ophthalmol. 2012;6:71-7doi: 10.2147/OPTH.S26105.
Doan, S. (2012). Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel. Clinical ophthalmology (Auckland, N.Z.), 671-7. https://doi.org/10.2147/OPTH.S26105
Doan, Serge. "Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel." Clinical ophthalmology (Auckland, N.Z.) vol. 6 (2012): 71-7. doi: https://doi.org/10.2147/OPTH.S26105
Doan S. Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel. Clin Ophthalmol. 2012;6:71-7. doi: 10.2147/OPTH.S26105. Epub 2012 Jan 11. PMID: 22275810; PMCID: PMC3261692.
Copy Download .nbib Format: NLM
The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart.

Korean journal of anesthesiology

Hur MJ, Kim H, Lee DK, Lim SH.
PMID: 22558503
Korean J Anesthesiol. 2012 Apr;62(4):358-64. doi: 10.4097/kjae.2012.62.4.358. Epub 2012 Apr 23.

BACKGROUND: Lipid-emulsion propofol (LP) has cardioprotective effects against ischemia-reperfusion injury, but it has lipid-related side effects. Microemulsion propofol (MP) is a lipid-free propofol emulsified with 10% purified poloxamer 188 (PP188). PP188 is a nonionic surfactant and has cardioprotective effects....

Cite
Hur MJ, Kim H, Lee DK, et al. The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart. Korean J Anesthesiol. 2012;62(4):358-64doi: 10.4097/kjae.2012.62.4.358.
Hur, M. J., Kim, H., Lee, D. K., & Lim, S. H. (2012). The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart. Korean journal of anesthesiology, 62(4), 358-64. https://doi.org/10.4097/kjae.2012.62.4.358
Hur, Min Jung, et al. "The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart." Korean journal of anesthesiology vol. 62,4 (2012): 358-64. doi: https://doi.org/10.4097/kjae.2012.62.4.358
Hur MJ, Kim H, Lee DK, Lim SH. The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart. Korean J Anesthesiol. 2012 Apr;62(4):358-64. doi: 10.4097/kjae.2012.62.4.358. Epub 2012 Apr 23. PMID: 22558503; PMCID: PMC3337383.
Copy Download .nbib Format: NLM
Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date.

International journal of pharmaceutical compounding

Pignato A, Pankaskie M, Birnie C.
PMID: 23965656
Int J Pharm Compd. 2010 Nov-Dec;14(6):522-5.

The purpose of this stability study was to determine the beyond-use date of the active ingredient methimazole extemporaneously prepared for transdermal absorption to treat feline hyperthyroidism. The methimazole was prepared in poloxamer lecithin organogel and subjected to a three-month...

Cite
Pignato A, Pankaskie M, Birnie C. Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date. Int J Pharm Compd. 2010;14(6):522-5
Pignato, A., Pankaskie, M., & Birnie, C. (2010). Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date. International journal of pharmaceutical compounding, 14(6), 522-5.
Pignato, Alyssa, et al. "Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date." International journal of pharmaceutical compounding vol. 14,6 (2010): 522-5.
Pignato A, Pankaskie M, Birnie C. Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date. Int J Pharm Compd. 2010 Nov-Dec;14(6):522-5. PMID: 23965656.
Copy Download .nbib Format: NLM
Preparation and evaluation of fenoterol hydrobromide suppositories.

Drug discoveries & therapeutics

Ghorab D, Refai H, Tag R.
PMID: 22466443
Drug Discov Ther. 2011 Dec;5(6):311-8. doi: 10.5582/ddt.2011.v5.6.311.

Fenoterol HBr is a bronchodilator known to be subject to first pass effect after oral administration. The aim of this study was to prepare and evaluate fenoterol HBr suppositories. Suppositories were prepared by a fusion method using different fatty...

Cite
Ghorab D, Refai H, Tag R. Preparation and evaluation of fenoterol hydrobromide suppositories. Drug Discov Ther. 2011;5(6):311-8doi: 10.5582/ddt.2011.v5.6.311.
Ghorab, D., Refai, H., & Tag, R. (2011). Preparation and evaluation of fenoterol hydrobromide suppositories. Drug discoveries & therapeutics, 5(6), 311-8. https://doi.org/10.5582/ddt.2011.v5.6.311
Ghorab, D, et al. "Preparation and evaluation of fenoterol hydrobromide suppositories." Drug discoveries & therapeutics vol. 5,6 (2011): 311-8. doi: https://doi.org/10.5582/ddt.2011.v5.6.311
Ghorab D, Refai H, Tag R. Preparation and evaluation of fenoterol hydrobromide suppositories. Drug Discov Ther. 2011 Dec;5(6):311-8. doi: 10.5582/ddt.2011.v5.6.311. PMID: 22466443.
Copy Download .nbib Format: NLM
In vitro dissolution study of atorvastatin binary solid dispersion.

Journal of advanced pharmaceutical technology & research

Jahan R, Islam MS, Tanwir A, Chowdhury JA.
PMID: 23662278
J Adv Pharm Technol Res. 2013 Jan;4(1):18-24. doi: 10.4103/2231-4040.107496.

The aim of the present study was to improve the solubility and dissolution rate of atorvastatin (ATV), a slight water-soluble drug, by solid dispersion (SD) technique using a hydrophilic carrier Poloxamer 188 (POL188). Physical mixing (PM) and solvent evaporation...

Cite
Jahan R, Islam MS, Tanwir A, et al. In vitro dissolution study of atorvastatin binary solid dispersion. J Adv Pharm Technol Res. 2013;4(1):18-24doi: 10.4103/2231-4040.107496.
Jahan, R., Islam, M. S., Tanwir, A., & Chowdhury, J. A. (2013). In vitro dissolution study of atorvastatin binary solid dispersion. Journal of advanced pharmaceutical technology & research, 4(1), 18-24. https://doi.org/10.4103/2231-4040.107496
Jahan, Rahat, et al. "In vitro dissolution study of atorvastatin binary solid dispersion." Journal of advanced pharmaceutical technology & research vol. 4,1 (2013): 18-24. doi: https://doi.org/10.4103/2231-4040.107496
Jahan R, Islam MS, Tanwir A, Chowdhury JA. In vitro dissolution study of atorvastatin binary solid dispersion. J Adv Pharm Technol Res. 2013 Jan;4(1):18-24. doi: 10.4103/2231-4040.107496. PMID: 23662278; PMCID: PMC3645364.
Copy Download .nbib Format: NLM
Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique.

Iranian journal of pharmaceutical research : IJPR

Esfandi E׳, Ramezani V, Vatanara A, Rouholamini Najafabadi A, Hadipour Moghaddam SP.
PMID: 25276181
Iran J Pharm Res. 2014;13(3):809-18.

Clarithromycin (CLM) is a member of macrolide family with broad spectrum antibiotic activity. It is practically insoluble in water and its poor solubility is pH dependent. In this study, series of nanosuspensions containing CLM and stabilizer such as HPMC,...

Cite
Esfandi E׳, Ramezani V, Vatanara A, et al. Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique. Iran J Pharm Res. 2014;13(3):809-18
Esfandi, E. �. �., Ramezani, V., Vatanara, A., Rouholamini Najafabadi, A., & Hadipour Moghaddam, S. P. (2014). Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique. Iranian journal of pharmaceutical research : IJPR, 13(3), 809-18.
Esfandi, Es ׳hagh, et al. "Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique." Iranian journal of pharmaceutical research : IJPR vol. 13,3 (2014): 809-18.
Esfandi E׳, Ramezani V, Vatanara A, Rouholamini Najafabadi A, Hadipour Moghaddam SP. Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique. Iran J Pharm Res. 2014;13(3):809-18. PMID: 25276181; PMCID: PMC4177641.
Copy Download .nbib Format: NLM
Temperature responsive nanoparticles: poloxamers as a modulator of Förster resonance energy transfer (FRET).

Nanoscale

Klep O, Bandera Y, Foulger SH.
PMID: 29741544
Nanoscale. 2018 May 17;10(19):9401-9409. doi: 10.1039/c8nr01278d.

An effective strategy to control the Förster resonance energy transfer (FRET) of a donor/acceptor emitter pair that were attached to a 60 nm poly(propargyl acrylate)(PA) nanoparticle using temperature variations was developed. The size dependent properties of a poly-(ethylene oxide)-poly-(propylene...

Cite
Klep O, Bandera Y, Foulger SH. Temperature responsive nanoparticles: poloxamers as a modulator of Förster resonance energy transfer (FRET). Nanoscale. 2018;10(19):9401-9409doi: 10.1039/c8nr01278d.
Klep, O., Bandera, Y., & Foulger, S. H. (2018). Temperature responsive nanoparticles: poloxamers as a modulator of Förster resonance energy transfer (FRET). Nanoscale, 10(19), 9401-9409. https://doi.org/10.1039/c8nr01278d
Klep, Oleksandr, et al. "Temperature responsive nanoparticles: poloxamers as a modulator of Förster resonance energy transfer (FRET)." Nanoscale vol. 10,19 (2018): 9401-9409. doi: https://doi.org/10.1039/c8nr01278d
Klep O, Bandera Y, Foulger SH. Temperature responsive nanoparticles: poloxamers as a modulator of Förster resonance energy transfer (FRET). Nanoscale. 2018 May 17;10(19):9401-9409. doi: 10.1039/c8nr01278d. PMID: 29741544.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 425 entries